These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 3239219)
1. [Quantitative and qualitative disorders of energy transformation in the myocardial contractile protein system--a pivotal process in the development of heart failure]. Karsanov NV; Magaldadze VA; Macharashvili TN; Sukoian GV; Tatulashvili DR Vestn Akad Med Nauk SSSR; 1988; (12):60-8. PubMed ID: 3239219 [No Abstract] [Full Text] [Related]
2. Energy transduction in the myocardial contractile protein system under normal conditions and in toxi-allergic myocarditis. Karsanov NV; Sukoyan GV; Tatulashvili DR Biomed Sci; 1991; 2(4):344-56. PubMed ID: 1797138 [TBL] [Abstract][Full Text] [Related]
3. [The action of a number of cardiac glycosides on an isolated system of myocardial contractile proteins in heart failure due to toxic-allergic myocarditis. The molecular mechanism]. Karsanov NV; Sukoian GV; Karsanov VN; Tatulashvili DR; Kipshidze NN Eksp Klin Farmakol; 1999; 62(4):18-25. PubMed ID: 10513330 [TBL] [Abstract][Full Text] [Related]
4. [Myocardial myofibrillary ATPase in cardiac failure]. Swynghedauw B; Meignan M; Piguet V; Hatt PY Arch Mal Coeur Vaiss; 1971 Nov; 64(11):1547-56. PubMed ID: 4260725 [No Abstract] [Full Text] [Related]
5. Myocardial metabolic changes in cardiac hypertrophy and heart failure. Fizelova A; Fizel A Recent Adv Stud Cardiac Struct Metab; 1972; 1():200-12. PubMed ID: 4283436 [No Abstract] [Full Text] [Related]
6. [The comparative efficacy and differences in the molecular mechanism of the inotropic action of cardiac glycosides and nonglycoside cardiotropic agents on the contractile protein system of the myocardium]. Karsanov NV; Kipshidze NN; Sukoian GV; Guchua ZI; Tatulashvili DR; Karsanov VN; Iarovaia EV; Magaldadze VA; Turmanauli GS Eksp Klin Farmakol; 1996; 59(3):28-33. PubMed ID: 8974579 [TBL] [Abstract][Full Text] [Related]
7. [Energy support and the contractile capacity of glycerinized myocardial fibers in experimental informational neurosis]. Karsanov NV; Khananashvili MM; Nakhapetova ZhA; Suknidze TsG; Kartvelishvili RG Fiziol Zh SSSR Im I M Sechenova; 1985 Jan; 71(1):113-9. PubMed ID: 4038666 [TBL] [Abstract][Full Text] [Related]
8. [Protein synthesis in the myocardium in experimental allergic lesion of the heart in rabbits]. Grozdova MD; Starostina IK Vopr Med Khim; 1973; 19(4):403-7. PubMed ID: 4788292 [No Abstract] [Full Text] [Related]
9. [The subcellular pathophysiology of heart failure due to toxic-allergic myocarditis and the action of refracterin on intracardiac hemodynamics and the functional state of the 3 subcellular cardiomyocyte systems responsible for the act of contraction-relaxation]. Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II; Guchua EI Patol Fiziol Eksp Ter; 1999; (3):3-8. PubMed ID: 10498985 [TBL] [Abstract][Full Text] [Related]
10. Altered expression of titin and contractile proteins in failing human myocardium. Hein S; Scholz D; Fujitani N; Rennollet H; Brand T; Friedl A; Schaper J J Mol Cell Cardiol; 1994 Oct; 26(10):1291-306. PubMed ID: 7869390 [TBL] [Abstract][Full Text] [Related]
11. [Pharmacological correction of disordered function of the myocardial contractile proteins]. Shevchenko AI Farmakol Toksikol; 1984; 47(6):43-6. PubMed ID: 6519255 [TBL] [Abstract][Full Text] [Related]
14. [The positive action of refracterin on the reserve potentials and metabolism of the myocardium during its overload in toxic-allergic myocarditis]. Karsanov NV; Sukoian GV; Dzhibgashvili IK; Tatulashvili DR; Gorelishvili II Patol Fiziol Eksp Ter; 1999; (4):10-6. PubMed ID: 10636764 [TBL] [Abstract][Full Text] [Related]
15. Sarcomeric dysfunction in heart failure. Hamdani N; Kooij V; van Dijk S; Merkus D; Paulus WJ; Remedios CD; Duncker DJ; Stienen GJ; van der Velden J Cardiovasc Res; 2008 Mar; 77(4):649-58. PubMed ID: 18055579 [TBL] [Abstract][Full Text] [Related]
16. [The action of strophanthin K and beta-acetyldigoxin in vitro on the energy transformation by the contractile protein system of the normal cardiomyocyte]. Karsanov NV; Macharashvili TN; Magaldadze VA Biull Eksp Biol Med; 1989 Dec; 108(12):686-9. PubMed ID: 2634440 [TBL] [Abstract][Full Text] [Related]
17. [Ways of correcting certain metabolic processes in the myocardium in myocardial insufficiency]. Chazov EI; Nikolaeva LF Arkh Patol; 1976; 38(9):3-8. PubMed ID: 17376 [TBL] [Abstract][Full Text] [Related]
18. [Proteins and nucleic acids in the chronicly insufficient myocardium]. Nowy H Verh Dtsch Ges Kreislaufforsch; 1968; 34():184-6. PubMed ID: 4242129 [No Abstract] [Full Text] [Related]
19. Titin, myosin light chains and C-protein in the developing and failing human heart. Morano I; Hädicke K; Grom S; Koch A; Schwinger RH; Böhm M; Bartel S; Erdmann E; Krause EG J Mol Cell Cardiol; 1994 Mar; 26(3):361-8. PubMed ID: 8028019 [TBL] [Abstract][Full Text] [Related]
20. Role of actin and myosin in the mechanism of the decrease of myocardial contractility and efficiency of energy transformation by myocardial myofibrils in chronic heart failure in humans. Karsanov NV; Guledani NE; Kuchava LT Bull Exp Biol Med; 2001 Nov; 132(5):1100-5. PubMed ID: 11865332 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]